Five year follow up on FFR guided PCI for Stable CAD – What Did We Learn From FAME2?
In the final follow up of the FAME 2 study, published in The New England Journal of Medicine, five year outcomes were reported comparing percutaneous coronary... Read more.
High Sensitivity Troponin I and Stable Coronary Artery Disease
A recent study published in the Journal of American College of Cardiology found an association between elevated concentrations of high sensitivity troponin I (hsTnI)... Read more.
Andexanet alfa: Rapid reversal of Factor Xa inhibitors
On Monday, March 12th at ACC 2018 in Orlando, Florida, an interim analysis from the ongoing ANNEXA-4 study demonstrated that the first- in-class reversal drug for... Read more.